{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:08:08Z","timestamp":1758629288251},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T00:00:00Z","timestamp":1323561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00432-011-1109-7","type":"journal-article","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T05:08:14Z","timestamp":1323493694000},"page":"425-430","source":"Crossref","is-referenced-by-count":6,"title":["Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi\u2019s sarcoma"],"prefix":"10.1007","volume":"138","author":[{"given":"Dong Ta","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Mei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing Ze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian Gang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,11]]},"reference":[{"key":"1109_CR1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0140-6736(90)90001-L","volume":"335","author":"V Beral","year":"1990","unstructured":"Beral V, Peterman TA, Berkelman RL, Jaffe HW (1990) Kaposi\u2019s sarcaoma among persons with AIDS: a sexually transmitted infection. Lancet 335:123\u2013128","journal-title":"Lancet"},{"key":"1109_CR2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1468-1293.2008.00608.x","volume":"9","author":"M Bower","year":"2008","unstructured":"Bower M, Collins S, Cottrill C, Cwynarski K, Montoto S, Nelson M, Nwokolo N, Powles T, Stebbing J, Wales N, Webb A (2008) British HIV association guidelines for HIV-associated malignancies 2008. HIV Med 9:336\u2013388","journal-title":"HIV Med"},{"key":"1109_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000051610","volume":"202","author":"L Brambilla","year":"2001","unstructured":"Brambilla L, Labianca R, Ferrucci SM, Taglioni M, Boneschi V (2001) Treatment of classical Kaposi\u2019s sarcoma with gemcitabine. Dermatology 202:119\u2013122","journal-title":"Dermatology"},{"key":"1109_CR4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1200\/JCO.1995.13.8.2005","volume":"13","author":"GP Canellos","year":"1995","unstructured":"Canellos GP, Petroni GR, Barcos M, Duggan DB, Peterson BA (1995) Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin\u2019s disease in relapse following MOPP. Cancer and Leukemia Group B. J Clin Oncol 13:2005\u20132011","journal-title":"J Clin Oncol"},{"key":"1109_CR5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0889-8588(05)70382-8","volume":"10","author":"BJ Dezube","year":"1996","unstructured":"Dezube BJ (1996) Clinical presentation and natural history of AIDS-related Kaposi\u2019s sarcoma. Hematol Oncol Clin North Am 10:1023\u20131029","journal-title":"Hematol Oncol Clin North Am"},{"key":"1109_CR6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/cncr.23264","volume":"112","author":"G Di Lorenzo","year":"2008","unstructured":"Di Lorenzo G, Di Trolio R, Montesarchio V, Palmieri G, Nappa P, Delfino M, De Placido S, Dezube BJ (2008) Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study. Cancer 112:1147\u20131152","journal-title":"Cancer"},{"key":"1109_CR7","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1200\/JCO.2002.12.038","volume":"20","author":"SR Evans","year":"2002","unstructured":"Evans SR, Krown SE, Testa MA, Cooley TP, Roenn JHV (2002) Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-rlated Kaposi\u2019s sarcoma: an AIDS clinical trails group clinical study. J Clin Oncol 20:3236\u20133241","journal-title":"J Clin Oncol"},{"key":"1109_CR8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/cncr.21791","volume":"106","author":"L Fardet","year":"2006","unstructured":"Fardet L, Stoebner PE, Bachelez H, Descamps V, Kerob D, Meunier L, Dandurand M, Morel P, Lebbe C (2006) Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection. Cancer 106:1785\u20131789","journal-title":"Cancer"},{"key":"1109_CR9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(91)80081-V","volume":"90","author":"PS Gill","year":"1991","unstructured":"Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bemstein-Singer M, Akil B, Espina BM, Krailo M et al (1991) Systemic treatment of AIDS-related Kaposi\u2019s sarcoma: results of a randomized trial. Am J Med 90:427\u2013433","journal-title":"Am J Med"},{"key":"1109_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1200\/JCO.1990.8.1.39","volume":"8","author":"GE Goodman","year":"1990","unstructured":"Goodman GE, Crowley JJ, Blasko JC, Livingston RB, Beck TM, Demattia MD, Bukowski RM (1990) Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study. J Clin Oncol 8:39\u201347","journal-title":"J Clin Oncol"},{"key":"1109_CR11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00042560-200007010-00013","volume":"24","author":"JL Jones","year":"2000","unstructured":"Jones JL, Hanson DL, Dworkin MS, Jaffe HW (2000) Incidence and trends in Kaposi\u2019s sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 24:270\u2013274","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1109_CR12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1200\/JCO.1984.2.10.1115","volume":"2","author":"LS Laubenstein","year":"1984","unstructured":"Laubenstein LS, Krigel RL, Odajnyk CM, Hymes KB, Friedman-kien A, wernz JC, Muggia FM (1984) Treatment of epidemic Kaposi\u2019s sarcoma with etoposide or a combination of doxorubicin, bleomycin and vinblastine. J Clin Oncol 2:1115\u20131120","journal-title":"J Clin Oncol"},{"key":"1109_CR13","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1200\/JCO.2002.12.065","volume":"20","author":"CN Papandreou","year":"2002","unstructured":"Papandreou CN, Daliani DD, Thall PF, Tu SM, Wang X, Reyes A, Troncoso P, Logothetis CJ (2002) Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20:3072\u20133080","journal-title":"J Clin Oncol"},{"key":"1109_CR14","first-page":"199","volume":"16","author":"V Raina","year":"2003","unstructured":"Raina V, Sharma A, Mohanti BK, Kumar R, Dawar R, Rath GK (2003) Etoposide, vinblastine, doxorubicin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin\u2019s disease. Natl Med J India 16:199\u2013203","journal-title":"Natl Med J India"},{"key":"1109_CR15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1182\/blood.V100.5.1634.h81702001634_1634_1640","volume":"100","author":"JA Sparano","year":"2002","unstructured":"Sparano JA, Weller E, Nazeer T, Habermann T, Traynor AE, Manalo J, Cassileth P (2002) Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493). Blood 100:1634\u20131640","journal-title":"Blood"},{"key":"1109_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00001622-199509000-00008","volume":"7","author":"MD Volm","year":"1995","unstructured":"Volm MD, von Roenn JH (1995) Treatment strategies for epidemic Kaposi\u2019s sarcoma. Curr Opin Oncol 7:429\u2013436","journal-title":"Curr Opin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1109-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-011-1109-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-011-1109-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T15:52:04Z","timestamp":1593359524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-011-1109-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,11]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1109"],"URL":"https:\/\/doi.org\/10.1007\/s00432-011-1109-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,11]]}}}